Key result
Acute administration of candesartan increased skeletal muscle microvascular blood volume by 68% and recruited cardiac muscle microvasculature in healthy humans.
Why the study?
Does acute administration of candesartan improve skeletal and cardiac muscle microvascular perfusion in healthy humans?
RCT (n=8)
Random order
No
Does acute administration of candesartan improve skeletal and cardiac muscle microvascular perfusion in healthy humans?
Acute AT1 receptor blockade with candesartan improves skeletal and cardiac muscle microvascular perfusion in healthy humans, providing a potential physiological mechanism for the cardiovascular benefits of ARBs.
Answers are grounded in this paper and cite their sources.
Supports microvascular mechanism for ARB benefits; extends evidence to acute effects in healthy human muscle.
CONTEXT: Angiotensin II type 1 receptor (AT(1)R) tone restricts muscle microvascular blood volume (MBV) and decreases muscle insulin delivery and glucose use. OBJECTIVE: The objective of the study was to examine whether acute AT(1)R blockade alters microvascular perfusion in skeletal and cardiac muscle in humans. SETTING: The study was conducted at the General Clinical Research Center at the University of Virginia. METHODS: Eight overnight-fasted healthy young adults were studied thrice in random order. In study 1, each subject received candesartan (32 mg) orally at time 0. In study 2, each subject received placebo at time 0 and a 1 mU/min · kg euglycemic insulin clamp from time 240 to 360 min. In study 3, each subject received candesartan (32 mg) orally at time 0 and insulin infusion from 240 to 360 min. Forearm skeletal and cardiac muscle MBV, microvascular flow velocity, and microvascular blood flow (MBF) were determined at baseline and at 240 and 360 min. RESULTS: Candesartan treatment acutely recruited microvasculature in both skeletal and cardiac muscle by significantly increasing MBV (P < 0.03 and P = 0.02, respectively) and MBF (P < 0.03 for both) without altering microvascular flow velocity. Insulin infusion significantly increased cardiac MBV (P = 0.02) and MBF (P < 0.02). Superimposing insulin infusion 4 h after candesartan ingestion did not further recruit microvasculature. Insulin-mediated whole-body glucose disposal did not differ with or without candesartan pretreatment. CONCLUSIONS: Acute AT(1)R blockade with candesartan recruits skeletal as well as cardiac muscle microvasculature in healthy humans without altering insulin-mediated whole-body glucose disposal. This may contribute to the observed improvement in the cardiovascular outcomes in patients receiving prolonged treatment with AT(1)R blockers.
No takes yet. Share an insight, caveat, or question.
Sauder et al. (2012) conducted an RCT in Healthy (n=8). Candesartan vs. Placebo was evaluated on Skeletal muscle microvascular blood volume (MBV) at 360 minutes (68% increase, p=<0.03). Acute administration of candesartan increased skeletal muscle microvascular blood volume by 68% and recruited cardiac muscle microvasculature in healthy humans.
Synapse has enriched 10 related papers. Consider them for comparative context: